期刊文献+

TCRP1基因启动子区CpG岛测序体系的建立

Establishment of a method for sequencing CpG islands located at the promoter region of TCRP1 gene
下载PDF
导出
摘要 目的建立可用于舌癌耐药蛋白1(TCRP1)基因启动子区CpG岛测序检测的反应体系。方法采用人肺癌A549细胞作为待测样品,以TCRP1启动子区CpG岛为靶片段设计特异扩增、测序引物,建立TCRP1启动子区CpG岛测序检测反应体系,并检测H1299、H460、Huh-7细胞株和2例患者肿瘤组织标本。结果建立了以P2-1[二甲基亚砜(DMSO)终浓度0%,降落聚合酶链反应(PCR)条件]联合P1-2(DMSO终浓度1%,常规PCR反应条件)为优选方案的TCRP1启动子区CpG岛测序检测体系,并成功检测了A549、H1299、H460、Huh-7细胞株和2例患者肿瘤组织标本。结论成功建立可用于TCRP1启动子区CpG岛测序的反应体系。 Objective To establish a method for sequencing the CpG islands located at promoter region of tongue cancer-resistant protein 1(TCRP1)gene.Methods A method for sequencing the CpG islands located at the promoter region of TCRP1 gene was established with specific polymerase chain reaction(PCR)and sequencing primers by using human cell line A549.Then human cell line H1299,H460,Huh-7and 2clinical samples were tested by using established method.Results An optimized sequencing system,consisted of P2-1[with 0% dimethyl sulphoxide(DMSO),using slow-down PCR conditions]and P1-2(with 1% DMSO,using normal PCR conditions),was successfully used in detection of human cell line H1299,H460,Huh-7and 2clinical samples,which could be applied for sequencing the CpG islands located at promoter region of TCRP1 gene.Conclusion A system for sequencing the CpG islands located at promoter region of TCRP1 gene was successfully established.
出处 《检验医学与临床》 CAS 2015年第7期891-894,共4页 Laboratory Medicine and Clinic
基金 教育部高等学校博士学科点专项科研基金资助项目(20124423110003) 广东省自然科学基金资助项目(S2012010008995)
关键词 舌癌耐药蛋白1 启动子 CPG岛 聚合酶链反应 基因测序 二甲基亚砜 tongue cancer-resistant protein 1 promoter CpG islands polymerase chain reaction DNA sequencing dimethyl sulphoxide
  • 相关文献

参考文献9

  • 1郑国沛,易思思,贾小婷,贺智敏.C-myc上调TCRP1表达与舌癌细胞对顺铂耐受相关[J].中国生物化学与分子生物学报,2014,30(3):272-278. 被引量:1
  • 2Bachmann HS, Siffert W,Frey UH. Successful amplifica- tion of extremely GC-rich promoter regions using a novel "slowdown PCR" technique[J]. Pharmacogenetics, 2003,13 (12) :759-766.
  • 3Deaton AM, Bird A. CpG islands and the regulation of transcription[J]. Genes Dev,2011,25(10) : 1010-1022.
  • 4Pratyush D,Tiwari S,Kumar A,et al. A new approach to touch down method using betaine as co-solvent for in- creased specificity and intensity of GC rich gene amplifica- tion[J]. Gene, 2012,497 (2) : 269-272.
  • 5Strien J,Sanft J, Mall G. Enhancement of PCR amplifica- tion of moderate GC-containing and highly GC-rich DNA sequences[J]. Mol Biotechnol,2013,54(3) ; 1048-1054.
  • 6Farell EM, Alexandre G. Bovine serum albumin further enhances the effects of organic solvents on increased yield of polymerase chain reaction of GC-rich templates [J/ OL]. BMC Res Notes, 2012-05-24[2014-12-[0], http;// www. ncbi. nlm. nih. gov/pubmed/22624992.
  • 7Jensen MA,Fukushima M,Davis RW. DMSO and betaine greatly improve amplification of GC-rich constructs in de novo synthesis[J/OL]. PLoS One, 2010-06-11 [2014-12- 10], http://www, ncbi. nlm. nih. gov/pmc/articles/ PMC2883997/.
  • 8Wei M, Deng J, Feng K, et al. Universal method facilita- ting the amplification of extremely GC-rich DNA frag- ments from genomic DNA[J]. Anal Chem, 2010,82 (14): 6303-6307.
  • 9Obradovic J, Jurisie V, Tosic N, et al. Optimization of PCR Conditions for Amplification of GC-Rich EGFR Promoter Sequence[J]. J Clin Labor Anal, 2013,27 (6): 487-493.

二级参考文献23

  • 1Rusthoven K E, Raben D, Song J I, et al. Survival and patterns of relapse in patients with oral tongue cancer [ J ]. J Oral Maxillofac Surg, 2010, 68(3) : 584-589.
  • 2Gu Y, Fan S, Xiong Y, et al. Cloning and functional characterization of TCRP1, a novel gene mediating resistance to cisplatin in an oral squamous cell carcinoma cell line [ J]. FEBS Lett, 2011, 585(6) : 881-887.
  • 3Zheng G, Zhou M, Ou X, et al. Identification of carbonic anhydrase 9 as a contributor to pingyangmycin-induced drug resistance in human tongue cancer cells [ J]. FEBS J, 2010, 277(21 ) : 4506-4518.
  • 4Cheng C, Alexander R, Min R, et al. Understanding transcriptional regulation by integrative analysis of transcription factor binding data[J]. Genome Res, 2012, 22(9) : 1658-1667.
  • 5Florea A M, Biisselberg D. Cisplatin as an anti-tumor drug: cellular mechanisms of activity, drug resistance and induced side effects [J]. Cancers (Basel), 2011, 3(1): 1351-1371.
  • 6Sun X J, Wang Z, Wang L, et al. A stable transcription factor complex nucleated by oligomeric AML1 -ETO controls leukaemogenesis[J]. Nature, 2013, 500 (7460): 93-97.
  • 7Kostrewa D, Zeller M E, Armache K J, et al. RNA polymerase II-TFIIB structure and mechanism of transcription initiation [ J ].Nature', 2009, 462(7271):323-330.
  • 8Fernandez P C, Frank S R, Wang L, et al. Genomic targets of the human c-Myc protein [ J ]. Genes Dev, 2003, 17 (9) : 1115- 1129.
  • 9Reavie L, Buckley S M, Loizou E, et al. Regulation of c-Myc ubiquitination controls chronic myelogenous leukemia initiation and progression[J]. Cancer Cell, 2013, 23(3) :362-375.
  • 10Kim J Y, Valencia T, Abu-Baker S, et al. c-Myc phosphorylation by PKCE represses prostate tumorigenesis [ J ]. Proc Natl Acad Sci U S A, 2013, 110(16) : 6418-6423.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部